Results 131 to 140 of about 58,406 (311)
Does Type of Infant Feeding Affect Phototherapy for Neonatal Hyperbilirubinemia? [PDF]
Abeer El Sakka +3 more
openalex +1 more source
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth +13 more
wiley +1 more source
Comparing the effect of clofibrate and phenobarbital on the newborns with hyperbilirubinemia [PDF]
The aim of treating hyperbilirubinemia is preventing the serum bilirubin to reach neurotoxic levels, which is done by phototherapy or blood transfusion. However, pharmacological treatments still remain vague.
Hamidi, Majid +2 more
core
Carboxyhemoglobin as an early predictor for pathological hyperbilirubinemia in preterm neonates
RehabH Ali Mostafa +3 more
openalex +1 more source
Background Neonatal hyperbilirubinemia remains one of the most common clinical conditions faced and one of the most common diagnoses requiring neonatal intensive care unit (NICU) admission, and this study aims to investigate whether carboxyhemoglobin ...
Dina Rabie +3 more
doaj +1 more source
Investigation of the relationship between cord clamping time and risk of hyperbilirubinemia [PDF]
Yüksel Yaşartekin +7 more
openalex +1 more source
Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas +3 more
wiley +1 more source
Gilbert syndrome in patients with inherited hemolytic anemia modifies the clinical phenotype
Gilbert syndrome is a benign condition due to UGT1A1 mutations frequently resulting in mild, indirect hyperbilirubinemia. Inherited hemolytic anemias often present with hyperbilirubinemia and hepatosplenomegaly.
Anika Agrawal, Jagdish Chandra
doaj +1 more source
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim +15 more
wiley +1 more source
We explore the allele and genotype distribution of UGT1A1 and BLVRA variants in individuals affected by neonatal hyperbilirubinemia in southern China.
XiuJu Liu +4 more
doaj +1 more source

